Data / Research funding / Connecticut / L2 Diagnostics, LLC
L2 Diagnostics, LLC: 14 NIH awards ($9.7M), fiscal years 2021 to 2026
L2 Diagnostics, LLC in New Haven, CT is funded under 14 NIH awards ($9.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- GKA7VH5LFR25
- State
- Connecticut
Awards
14 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,948,061 | January 21, 2019 | July 31, 2025 | FIKRIG, EROL | reporter.nih.gov |
| An antigen-detection assay to diagnose Babesia microti infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,384,164 | January 10, 2018 | May 31, 2024 | LEDIZET, MICHEL | reporter.nih.gov |
| The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $599,938 | July 17, 2024 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $599,866 | July 8, 2024 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $599,740 | June 1, 2024 | May 31, 2027 | ANTHONY, KAREN G. | reporter.nih.gov |
| Therapeutic vaccine platform to boost immune responses in Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $599,471 | August 1, 2025 | July 31, 2027 | ANTHONY, KAREN G. | reporter.nih.gov |
| A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $599,028 | August 4, 2021 | July 31, 2024 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $597,612 | May 1, 2024 | April 30, 2027 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $300,000 | December 1, 2024 | November 30, 2025 | LEDIZET, MICHEL | reporter.nih.gov |
| PfAg, a multivalent peptide vaccine against malaria | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $299,954 | September 15, 2025 | August 31, 2027 | CHUANG, YU-MIN | reporter.nih.gov |
| A vaccine targeting mosquito metabolic pathways to eradicate malaria | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $299,644 | September 23, 2025 | August 31, 2027 | CHUANG, YU-MIN | reporter.nih.gov |
| Vaccination against Zika virus infection using mosquito NeSt1 protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $293,886 | June 16, 2020 | May 31, 2023 | LEDIZET, MICHEL | reporter.nih.gov |
| A Point of Care Test for Babesia microti | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $293,142 | September 21, 2025 | August 31, 2027 | SUTHERLAND, ALAN GORDON | reporter.nih.gov |
| A viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus in a tick transmission model | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $281,786 | September 23, 2025 | August 31, 2027 | MARIN LOPEZ, ALEJANDRO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 10 | $3,273,011 | 0 | $0 |
| 2024 | 5 | $2,178,361 | 0 | $0 |
| 2023 | 1 | $979,482 | 0 | $0 |
| 2022 | 3 | $1,979,956 | 0 | $0 |
| 2021 | 3 | $1,285,482 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 12 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
Topics of its NIH awards
- Emerging Infectious Diseases
- Infectious Diseases
- Vector-Borne Diseases
- Rare Diseases
- Biotechnology
- Prevention
- Immunization
- Vaccine Related
- Translational Research
- Orphan Drug
- Tickborne Diseases
- Biodefense and Related Countermeasures
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.